Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinha, S.
Right arrow Articles by Naritoku, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinha, S.
Right arrow Articles by Naritoku, D. K.
Neurology 2000;55:722-724
© 2000 American Academy of Neurology


Brief Communications

Intravenous valproate is well tolerated in unstable patients with status epilepticus

Shobhit Sinha, MBBS and Dean K. Naritoku, MD

From the Departments of Neurology (S. Sinha and Dr. Naritoku) and Pharmacology (Dr. Naritoku), Southern Illinois University, Springfield.

Address correspondence and reprint requests to Dr. Dean K. Naritoku, Department of Neurology, Southern Illinois University, PO Box 19637, Springfield, IL 62794-9637; e-mail: dnaritoku{at}siumed.edu

The authors reviewed hospital records of 13 patients with status epilepticus and hypotension who received IV valproate therapy. Most patients were elderly (74.4 ± 12.5 [SD] years) and received a loading dose of valproate of 25.1 ± 5.0 mg/kg (range 14.7 to 32.7), at a rate of 36.6 ± 25.1 mg/min (range 6.3 to 100). There were no significant changes in blood pressure, pulse, or use of vasopressors. The data suggest that valproate loading is well tolerated, even in patients with cardiovascular instability.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
N. A. Oberheim, G.-F. Tian, X. Han, W. Peng, T. Takano, B. Ransom, and M. Nedergaard
Loss of Astrocytic Domain Organization in the Epileptic Brain
J. Neurosci., March 26, 2008; 28(13): 3264 - 3276.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
D. J. Costello and A. J. Cole
Treatment of Acute Seizures and Status Epilepticus
J Intensive Care Med, November 1, 2007; 22(6): 319 - 347.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
S. S. Chung, N. C. Wang, and D. M. Treiman
Comparative Efficacy and Safety of Antiepileptic Drugs for the Treatment of Status Epilepticus
Journal of Pharmacy Practice, April 1, 2007; 20(2): 137 - 146.
[Abstract] [PDF]


Home page
NeurologyHome page
U. K. Misra, J. Kalita, and R. Patel
Sodium valproate vs phenytoin in status epilepticus: a pilot study.
Neurology, July 25, 2006; 67(2): 340 - 342.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
U. Idrees and M. Londner
Pharmacotherapy Overview of Seizure Management in the Adult Emergency Department
Journal of Pharmacy Practice, October 1, 2005; 18(5): 394 - 411.
[Abstract] [PDF]


Home page
NeurologyHome page
A. O. Rossetti, E. B. Bromfield, N. A. Limdi, E. Faught, and J. Burneo
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurology, August 9, 2005; 65(3): 500 - 501.
[Full Text] [PDF]


Home page
NeurologyHome page
N. A. Limdi, A. V. Shimpi, E. Faught, C. R. Gomez, and J. G. Burneo
Efficacy of rapid IV administration of valproic acid for status epilepticus
Neurology, January 25, 2005; 64(2): 353 - 355.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. W. Wheless, B. R. Vazquez, A. M. Kanner, R. E. Ramsay, L. Morton, and J. M. Pellock
Rapid infusion with valproate sodium is well tolerated in patients with epilepsy
Neurology, October 26, 2004; 63(8): 1507 - 1508.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. Kumar, C. J Vallis, and C. M Hall
Intravenous Valproate Associated with Circulatory Collapse
Ann. Pharmacother., December 1, 2003; 37(12): 1797 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
T. P. Bleck
Refractory Status Epilepticus in 2001
Arch Neurol, February 1, 2002; 59(2): 188 - 189.
[Full Text] [PDF]


Home page
Arch NeurolHome page
S. A. Mayer, J. Claassen, J. Lokin, F. Mendelsohn, L. J. Dennis, and B.-F. Fitzsimmons
Refractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Arch Neurol, February 1, 2002; 59(2): 205 - 210.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
C A Graham and M W G Gordon
Status epilepticus in accident and emergency: a difficult case
Emerg. Med. J., November 1, 2001; 18(6): 492 - 493.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.